Affiliation:
1. Pharmaceutical Sciences Statistics Pfizer Research and Development Groton Connecticut USA
2. Global CMC Pfizer Research and Development Groton Connecticut USA
Abstract
AbstractIn vitro dissolution testing is a regulatory required critical quality measure for solid dose pharmaceutical drug products. Setting the acceptance criteria to meet compendial criteria is required for a product to be filed and approved for marketing. Statistical approaches for analyzing dissolution data, setting specifications and visualizing results could vary according to product requirements, company's practices, and scientific judgements. This paper provides a general description of the steps taken in the evaluation and setting of in vitro dissolution specifications at release and on stability.
Reference8 articles.
1. Guidance for Industry: extended release oral dosage forms: development evaluation and application of in vitro/in vivo correlations.https://www.fda.gov/downloads/drugs/guidances/ucm070239.pdf
2. ICH Q1E.http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q1E/Step4/Q1E_Guideline.pdf
3. Simple methods for determination of the release limits for drug products
4. Drug Shelf Life and Release Limits Estimation Based on Manufacturing Process Capability